You expect more from us. In fact, you’re counting on it. And we’re delivering for you.
At University of Iowa Holden Comprehensive Cancer Center, our highly experienced physicians and staff are dedicated to taking care of you, not just your cancer. As part of a nationally recognized cancer center, our team focuses on every aspect of leukemia -- our clinicians are also top researchers, finding new and innovative treatments and therapies, as well as identifying genetic links that may pinpoint risk. We are on the leading edge of leukemia research, always searching for ways to make the best cancer treatment even better.
Holden Comprehensive Cancer Center is the only institution in Iowa to hold the prestigious designation of being a Comprehensive Cancer Center by the National Cancer Institute (NCI). What that means for you is that we are recognized among the leading cancer centers in the United States; NCI-designated Comprehensive Cancer Centers are rated in the top 4 percent of the approximately 1,500 cancer centers in the United States.A recent study published in the journal Cancer showed that patients treated at NCI designated cancer centers have better survival outcomes than patients treated at non-NCI designated cancer centers.
To be considered a “comprehensive” center means our teams have expertise in clinical, laboratory and population-based research. Our doctors and staff are on top of the newest developments in cancer research, treatment and diagnosis.
That means our team of experts will design a treatment plan that is tailored to your individual needs – we don’t believe in “one size fits all.”
Our multidisciplinary team is ready to offer all of the services you need for your leukemia care. We know no one wants to stay in the hospital longer than necessary, so we work especially hard to make sure your treatment options are done on an out-patient basis, allowing you to rest in the comfort of your own home.
Clinical trials is where research meets patient care. A great deal of research is done behind the scenes in laboratories, long before clinical trials can even begin. Clinical trials are research studies that test out the latest treatments and drugs that are not yet available to the wider public. These new treatments have the potential to improve your quality of life or increase your chances of survival.
For example, one of our studies involves patients with acute lymphoblastic leukemia (ALL). Researchers are trying to better understand the causes of leukemia and to develop improved methods to diagnose and treat the disease. Previous research indicates ALL may be divided into groups based on the chromosomes of leukemia cells. This study is investigating if an individual's response to treatment is related to the particular ALL type.
See a full list and learn more about clinical trials at Holden Comprehensive Cancer Center.
Our work is made possible in part by the support of donors through charitable giving. Friends of Holden Comprehensive Cancer Center can become partners in the effort to control and ultimately cure cancer. Learn how you can help us make a difference for cancer patients.
Noah was a typical college student... until he was diagnosed with leukemia.Follow Noah's story as he moved through treatment to recovery
Carol's leukemia returned when she was 26 weeks pregnant.Learn how Carol went from pregnant with leukemia to a proud mother and cancer survivor
We bring experts from different fields of medicine to work together as a team called a multidisciplinary oncology group. Because many leukemia patients require more than one form of treatment, our team meets regularly to discuss the best course of treatment and works together to design the best personalized plan for every patient. The team includes medical oncologists, radiation oncologists, social workers, pathologists, pediatric oncologists, pharmacists, nurses, and laboratory-based scientists. Our team of specialists focuses not just on leukemia, but on your leukemia.